Literature DB >> 35554757

Higher basophil count decreases narcolepsy risk: a Mendelian randomization study.

Ang Li1, Hao Li1, Junyang Xie1, Jianlei Xie1, Wenjing Liao1, Lijuan Song1, Xiaowen Zhang2.   

Abstract

BACKGROUND: Blood cell properties effectively reflect immune status. Basophil and CD8+ CD27+ T cell levels are correlated with narcolepsy, but their causal association is unclear. This study aims to evaluate the causality between blood cell count and narcolepsy risk at the genetic level.
METHODS: Two-sample Mendelian randomization (MR) analyses were performed on 35 published blood cell properties, using genome-wide association study (GWAS) datasets and one published GWAS dataset of narcolepsy, to explore causality between blood cell count and narcolepsy risk. Inverse variance weighted, MR-Egger, and weighted median approaches were employed for the MR analysis, odds ratio (OR) calculations, and heterogeneity tests of single nucleotide polymorphisms were conducted with the TwoSampleMR package in R. Multivariable Mendelian randomization (MVMR) was used to adjust the analysis further and eliminate the mediation effect between exposures.
RESULTS: Basophil counts, total basophil neutrophil counts, total neutrophil eosinophil counts, granulocyte counts, and myeloid white cell counts showed inverse associations with narcolepsy risk based on the two-sample MR analysis. MVMR confirmed that only basophil counts were significantly associated with narcolepsy risk for the blood cell properties tested (OR = 0.23, 95% confidence interval 0.08-0.62; p = 0.004, power = 99.99%). Each standard deviation increase in basophil count (0.03 per nL), compared to the median level (0.04 per nL), decreased narcolepsy risk by 77%.
CONCLUSION: Higher white blood cell counts, especially basophil counts, are protective factors for narcolepsy. Basophil counts has great potential to be used as a new biomarker to shorten diagnostic delay and to monitor the therapeutic effects of treatments for narcolepsy.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Basophil count; Causality; Mendelian randomization; Narcolepsy; Protective factor

Mesh:

Year:  2022        PMID: 35554757     DOI: 10.1007/s10072-022-06123-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  34 in total

Review 1.  Narcolepsy.

Authors:  Thomas E Scammell
Journal:  N Engl J Med       Date:  2015-12-31       Impact factor: 91.245

Review 2.  Genetic and familial aspects of narcolepsy.

Authors:  E Mignot
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

3.  Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.

Authors:  Fang Han; Ling Lin; Simon C Warby; Juliette Faraco; Jing Li; Song X Dong; Pei An; Long Zhao; Ling H Wang; Qian Y Li; Han Yan; Zhan C Gao; Yuan Yuan; Kingman P Strohl; Emmanuel Mignot
Journal:  Ann Neurol       Date:  2011-08-22       Impact factor: 10.422

Review 4.  Delayed diagnosis of narcolepsy: characterization and impact.

Authors:  Michael J Thorpy; Ana C Krieger
Journal:  Sleep Med       Date:  2014-02-15       Impact factor: 3.492

Review 5.  Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.

Authors:  Claudio L A Bassetti; Antoine Adamantidis; Denis Burdakov; Fang Han; Steffen Gay; Ulf Kallweit; Ramin Khatami; Frits Koning; Brigitte R Kornum; Gert Jan Lammers; Roland S Liblau; Pierre H Luppi; Geert Mayer; Thomas Pollmächer; Takeshi Sakurai; Federica Sallusto; Thomas E Scammell; Mehdi Tafti; Yves Dauvilliers
Journal:  Nat Rev Neurol       Date:  2019-07-19       Impact factor: 42.937

6.  Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States.

Authors:  Jonathan Duffy; Eric Weintraub; Claudia Vellozzi; Frank DeStefano
Journal:  Neurology       Date:  2014-10-15       Impact factor: 9.910

7.  Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.

Authors:  Hyun Hor; Zoltán Kutalik; Yves Dauvilliers; Armand Valsesia; Gert J Lammers; Claire E H M Donjacour; Alex Iranzo; Joan Santamaria; Rosa Peraita Adrados; José L Vicario; Sebastiaan Overeem; Isabelle Arnulf; Ioannis Theodorou; Poul Jennum; Stine Knudsen; Claudio Bassetti; Johannes Mathis; Michel Lecendreux; Geert Mayer; Peter Geisler; Antonio Benetó; Brice Petit; Corinne Pfister; Julie Vienne Bürki; Gérard Didelot; Michel Billiard; Guadalupe Ercilla; Willem Verduijn; Frans H J Claas; Peter Vollenweider; Peter Vollenwider; Gerard Waeber; Dawn M Waterworth; Vincent Mooser; Raphaël Heinzer; Jacques S Beckmann; Sven Bergmann; Mehdi Tafti
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

8.  Twin studies in narcolepsy.

Authors:  M Partinen; C Hublin; J Kaprio; M Koskenvuo; C Guilleminault
Journal:  Sleep       Date:  1994-12       Impact factor: 5.849

Review 9.  Autoimmunity in narcolepsy.

Authors:  Melodie Bonvalet; Hanna M Ollila; Aditya Ambati; Emmanuel Mignot
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

10.  Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.

Authors:  Adi Aran; Ling Lin; Sona Nevsimalova; Giuseppe Plazzi; Seung Chul Hong; Karin Weiner; Jamie Zeitzer; Emmanuel Mignot
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.